SciVision Biotech Reports 1Q Net Profit of NT$22.0 Million
SciVision Biotech reported first-quarter net profit of NT$22.0 million, unchanged from the year-earlier quarter. Revenue was NT$205.322 million and pretax profit was NT$35.682 million in both periods.